PharmiWeb8h
Verisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AG
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") announces that on March 28, 2025, it mutually agreed with SunRegen Healthcare AG ("SunRegen") ...
PharmiWeb8h
1933 Industries Reports Second Quarter 2025 Financial Results
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to ...
PharmiWeb13h
Global Animal Health Market Size, Share and Growth is Expand at 8-9% CAGR by 2029
Global Animal Health Market is expected to grow at a rate of 8-9% by 2029. Growing awareness of animal health products, ...
PharmiWeb13h
Healthcare Revenue Cycle Management Market is Expected to Reach ~11–12% CAGR by 2027
Market is expected to grow at a rate of ~11-12% by 2027. The growing demand for workflow optimization in healthcare organizations, regulatory requirements and government initiatives to boost the ...
PharmiWeb13h
Bioanalytical Services Market Outlook: Set for Double-Digit CAGR Growth by 2027
Global Bioanalytical Services Market is anticipated to witness a healthy double-digit growth rate by 2027. The rising ...
PharmiWeb13h
Global Home Healthcare Services Market Set to Grow at ~8–10% CAGR by 2029
The Global Home Healthcare Services Market will witness a CAGR of 9-10% by 2029. The key factors driving the home healthcare ...
PharmiWeb13h
Clinical Trials Market Expands at 6-7% CAGR: Driving Breakthroughs in Medical Research
The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...
PharmiWeb13h
AAVantgarde and TIGEM Publish Groundbreaking Research in Science Advances
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company, in collaboration with the Telethon Institute of Genetics and Medicine (TIGEM), announces the publication of their preclinical ...
PharmiWeb13h
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...
PharmiWeb13h
IMFINZI® (durvalumab) approved in the US as first…
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
PharmiWeb15h
VIVA Pediatric Healthcare Expands With Acquisition of Two PPECCs in Longview and Lubbock, Texas
RICHARDSON, TEXAS / ACCESS Newswire / March 31, 2025 / VIVA Pediatric Healthcare proudly announces the expansion of its pediatric care services with the acquisition of two Prescribed Pediatric ...
PharmiWeb16h
CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results
BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...